| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −5.1× | −1.7× | |
| Price / Book | 1.7× | 2.0× | |
| Price / Sales | 0.2× | 4.0× | |
| Price / Free cash flow | 7.9× | −1.6× | |
| EV / EBITDA | −6.8× | −1.1× | |
| Earnings yield | −19.5% | −14.4% | |
| Free cash flow yield | 12.6% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.14 | −0.71% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $252.09 | −1.36% | $607.51B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.22 | −0.77% | $500.48B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $401.96 | +0.13% | $360.8B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.77 | −0.81% | $357.17B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.21 | −0.27% | $277.88B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.05 | −0.22% | $255.98B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $676.93 | −1.89% | $250.29B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.11 | −1.24% | $230.91B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.59 | −1.02% | $191.68B | 22.8× | 37.5% | +32.0% |
